ATLAS / Macro Radar / Reporting / PRME

Prime Medicine, Inc. (PRME) reporting calendar

Prime Medicine, Inc. files periodic reports with the SEC as PRME on Nasdaq. Atlas tracks 15 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
26 Jul 2026 – 19 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
15

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open PRME market profile Latest filing on SEC EDGAR ↗ Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001628280-26-031726
10-K31 Dec 20253 Mar 202662 days0001628280-26-013569
10-Q30 Sep 20257 Nov 202538 days0001628280-25-050422
10-Q30 Jun 20257 Aug 202538 days0001628280-25-038619
10-Q31 Mar 20258 May 202538 days0001628280-25-023486
10-K31 Dec 202428 Feb 202559 days0001628280-25-008884
10-Q30 Sep 202412 Nov 202443 days0001628280-24-047130
10-Q30 Jun 20248 Aug 202439 days0001628280-24-035893
10-Q31 Mar 202410 May 202440 days0001628280-24-022473
10-K31 Dec 20231 Mar 202461 days0001628280-24-008116
10-Q30 Sep 20233 Nov 202334 days0001628280-23-036777
10-Q30 Jun 20237 Aug 202338 days0001628280-23-027772
10-Q31 Mar 202311 May 202341 days0001628280-23-017423
10-K31 Dec 20229 Mar 202368 days0001628280-23-007266
10-Q30 Sep 202214 Nov 202245 days0001628280-22-029889

Source: SEC EDGAR company submissions for CIK 0001894562. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.